PURPOSE:Type 2 diabetes is associated with increased risk of cardiovascular disease and elevated C-reactive protein (CRP) levels. Aerobic exercise training has been shown to improve CRP; however, there are limited data evaluating the effect of other exercise training modalities (aerobic, resistance, or combination training) in individuals with type 2 diabetes. METHODS:Participants (n = 204) were randomized to an aerobic exercise (aerobic), resistance exercise (resistance), or a combination of both (combination) for 9 months. CRP was evaluated at baseline and at follow-up. RESULTS:Baseline CRP was correlated with fat mass, waist circumference, body mass index, and VO(2peak) ̇(P < 0.05). CRP was not reduced after aerobic (0.16 mg·L(-1), 95% confidence interval (CI) = -1.0 to 1.3 mg·L(-1)), resistance (-0.03 mg·L(-1), 95% CI = -1.1 to 1.0 mg·L(-1)), or combination (-0.49 mg·L(-1), 95% CI = -1.5 to 0.6 mg·L(-1)) training compared to control (0.35 mg·L(-1), 95% CI = -1.0 to 1.7 mg·L(-1)). Changes in fasting glucose (r = 0.20, P = 0.009), glycated hemoglobin (HbA1c) (r = 0.21, P = 0.005), and fat mass (r = 0.19, P = 0.016) were associated with reductions in CRP but not with change in fitness or weight (P > 0.05). There were significant trends observed for CRP among tertiles of change in HbA1c (P = 0.009) and body fat (P = 0.040). CONCLUSIONS: Aerobic, resistance, or a combination of both did not reduce CRP levels in individuals with type 2 diabetes. However, exercise-related improvements in HbA1c, fasting glucose, and fat mass were associated with reductions in CRP.
RCT Entities:
PURPOSE:Type 2 diabetes is associated with increased risk of cardiovascular disease and elevated C-reactive protein (CRP) levels. Aerobic exercise training has been shown to improve CRP; however, there are limited data evaluating the effect of other exercise training modalities (aerobic, resistance, or combination training) in individuals with type 2 diabetes. METHODS:Participants (n = 204) were randomized to an aerobic exercise (aerobic), resistance exercise (resistance), or a combination of both (combination) for 9 months. CRP was evaluated at baseline and at follow-up. RESULTS: Baseline CRP was correlated with fat mass, waist circumference, body mass index, and VO(2peak) ̇(P < 0.05). CRP was not reduced after aerobic (0.16 mg·L(-1), 95% confidence interval (CI) = -1.0 to 1.3 mg·L(-1)), resistance (-0.03 mg·L(-1), 95% CI = -1.1 to 1.0 mg·L(-1)), or combination (-0.49 mg·L(-1), 95% CI = -1.5 to 0.6 mg·L(-1)) training compared to control (0.35 mg·L(-1), 95% CI = -1.0 to 1.7 mg·L(-1)). Changes in fasting glucose (r = 0.20, P = 0.009), glycated hemoglobin (HbA1c) (r = 0.21, P = 0.005), and fat mass (r = 0.19, P = 0.016) were associated with reductions in CRP but not with change in fitness or weight (P > 0.05). There were significant trends observed for CRP among tertiles of change in HbA1c (P = 0.009) and body fat (P = 0.040). CONCLUSIONS: Aerobic, resistance, or a combination of both did not reduce CRP levels in individuals with type 2 diabetes. However, exercise-related improvements in HbA1c, fasting glucose, and fat mass were associated with reductions in CRP.
Authors: Raul A Martins; Ana P Neves; Manuel J Coelho-Silva; Manuel T Veríssimo; Ana Maria Teixeira Journal: Eur J Appl Physiol Date: 2010-05-01 Impact factor: 3.078
Authors: Sheri R Colberg; Ann L Albright; Bryan J Blissmer; Barry Braun; Lisa Chasan-Taber; Bo Fernhall; Judith G Regensteiner; Richard R Rubin; Ronald J Sigal Journal: Med Sci Sports Exerc Date: 2010-12 Impact factor: 5.411
Authors: Mark J Dekker; SoJung Lee; Robert Hudson; Katherine Kilpatrick; Terry E Graham; Robert Ross; Lindsay E Robinson Journal: Metabolism Date: 2007-03 Impact factor: 8.694
Authors: S Balducci; S Zanuso; A Nicolucci; F Fernando; S Cavallo; P Cardelli; S Fallucca; E Alessi; C Letizia; A Jimenez; F Fallucca; G Pugliese Journal: Nutr Metab Cardiovasc Dis Date: 2009-08-19 Impact factor: 4.222
Authors: Leslie A Knaub; Sylvia McCune; Adam J Chicco; Matthew Miller; Russell L Moore; Nicholas Birdsey; Monique I Lloyd; Juan Villarreal; Amy C Keller; Peter A Watson; Jane E B Reusch Journal: Diab Vasc Dis Res Date: 2012-11-16 Impact factor: 3.291
Authors: Neil M Johannsen; Damon L Swift; Carl J Lavie; Conrad P Earnest; Steven N Blair; Timothy S Church Journal: Sports Med Date: 2016-12 Impact factor: 11.136